Abstract
Cefodizime was tested against 100 strains of Neisseria gonorrhoeae with varying susceptibility patterns to penicillin. Agar-dilution minimum inhibitory concentrations (MIC) and disk diffusion susceptibility testing were performed in triplicate for each strain according to National Committee for Clinical Laboratory Standards (NCCLS) guidelines to establish susceptibility interpretive criteria for this β-lactamase-stable cephalosporin. Cefodizime was very active against these strains of N. gonorrhoeae, with a MIC 50 of only 0.008 μg/ml. Because no resistant strains were documented, a single susceptible criterion of ⩽0.05 μg/ml (⩾31 mm) was proposed to predict clinical success after a single intramuscular (i.m.) dose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
